Home
About
Overview
Sharing Data
ORCID
Help
History (11)
beta-MSH
Cohen, Ronald N.
The effect of darapladib on plasma lipoprotein-associated phospholipase A2 activity and cardiovascular biomarkers in patients with stable coronary heart disease or coronary heart disease risk equivalent: the results of a multicenter, randomized, double-blind, placebo-controlled study.
Paroxetine treatment of pathological gambling: a multi-centre randomized controlled trial.
Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia.
See All 11 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia.
Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia. N Engl J Med. 2017 03 09; 376(10):917-927.
View in:
PubMed
subject areas
Adolescent
Adult
Aged
Antineoplastic Agents
Antineoplastic Combined Chemotherapy Protocols
Cross-Over Studies
Cytarabine
Cytogenetic Analysis
Female
Follow-Up Studies
Humans
Imatinib Mesylate
Intention to Treat Analysis
Interferon-alpha
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Male
Middle Aged
Protein Kinase Inhibitors
Survival Analysis
Young Adult
authors with profiles
Richard A. Larson